चौदह साल बाद प्रयाग में रात्रि प्रवास करेंगे अखिलेश

प्रयागराज, जून 28 -- प्रयागराज। समाजवादी पार्टी के राष्ट्रीय अध्यक्ष अखिलेश यादव एक बार फिर प्रयागराज की सियासी जमीन पर सक्रिय नजर आएंगे। करीब 14 साल बाद वह प्रयागराज में रात्रि प्रवास करेंगे। आगामी व... Read More

Maha: Minister Patil appeals public to take initiative to make entire society healthy, strong

Sangli, June 28 -- Maharashtra and district guardian minister Chandrakant Patil today said that as a strong society and a strong nation are made from healthy children, everyone should take initiative ... Read More

Tlangnuam FC storm to AIFF Futsal Club Championship title

Bhavnagar (Gujarat), June 28 -- Tlangnuam Futsal Club (Mizoram) defeated Progressive Sports Academy (Gujarat) 9-5 in a gripping final of the AIFF Futsal Club Championship2025-26 at the SAG Indoor Stad... Read More

Britain's Emma Raducanu 'plans to play' at Wimbledon despite injury setback

London, June 28 -- Britain's Emma Raducanu says she "plans to play" at Wimbledon on Monday despite her participation being put into serious doubt because of a leg injury. Raducanu, 23, made the decis... Read More

Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, June 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More

Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, June 28 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More

Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, June 28 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More

Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, June 28 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More

Singapore Clinical Trial: A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors, including Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors

Singapore, June 28 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembr... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension (PALM-PAH)

Singapore, June 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Eval... Read More

• ««
• «
• 169728
• 169729
• 169730
• 169731
• 169732
• 169733
• 169734
• 169735
• 169736
• 169737
• »
• »»